Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Sign up Log in

Upstream Bio, Inc. Director's Dealing 2024

Dec 17, 2024

32187_dirs_2024-12-17_1aa5a3d4-65bd-4c0e-a071-6cdae23f0b4b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Upstream Bio, Inc. (UPB)
CIK: 0002022626
Period of Report: 2024-12-16

Reporting Person: Ambrose Allison (N/A)

More from Upstream Bio, Inc.

Interim / Quarterly Report 2026
May 13
Regulatory Filings 2026
May 13
Regulatory Filings 2026
Mar 26
Director's Dealing 2026
Mar 17
Director's Dealing 2026
Mar 17
Regulatory Filings 2026
Feb 11
Regulatory Filings 2026
Feb 11
Director's Dealing 2026
Jan 6
Director's Dealing 2026
Jan 6
Director's Dealing 2026
Jan 6
View all filings →